New pill offers hope for PNH patients with persistent anemia
NCT ID NCT06715943
First seen Nov 01, 2025 · Last updated May 23, 2026 · Updated 20 times
Summary
This study tested an experimental pill called HRS-5965 in 39 adults with paroxysmal nocturnal hemoglobinuria (PNH) who still had anemia despite using standard anti-C5 antibody drugs. The goal was to see if the pill could raise hemoglobin levels and reduce the need for blood transfusions. Participants took the capsule for 24 weeks, and researchers measured blood counts and other markers. The trial is now complete.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PAROXYSMAL NOCTURNAL HEMOGLOBINURIA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Hematology Hospital of Chinese Academy of Medical Sciences
Tianjin, Tianjin Municipality, 30000, China
-
Tianjin Medical University General Hospital
Tianjin, Tianjin Municipality, 30000, China
Conditions
Explore the condition pages connected to this study.